{"name":"Humedics GmbH","slug":"humedics-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"13-C-Methacetin","genericName":"13-C-Methacetin","slug":"13-c-methacetin","indication":"Assessment of hepatic metabolic function and liver synthetic capacity","status":"phase_3"}]}],"pipeline":[{"name":"13-C-Methacetin","genericName":"13-C-Methacetin","slug":"13-c-methacetin","phase":"phase_3","mechanism":"13-C-Methacetin is a stable isotope-labeled tracer used to assess hepatic metabolic function and liver synthetic capacity.","indications":["Assessment of hepatic metabolic function and liver synthetic capacity","Evaluation of cirrhosis severity and prognosis","Monitoring of liver disease progression"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxPckVZdUR5UG1jeWRoUGF6NnJiN1VoLTh6VmJQVmNoS0NiT2VXTnl0c2FFZXJRM3ozcU9FeVJubnpRU3FINFQ3dGVTZ196dTc4SnAwbzNTWU4wMElXT0FueDQ2NXVFdUNOdEpXczBPbV84YUlqNzlvNHZrX2dIVm9VZE1ZakNSUWQ5RUY2Y3B2dHozNGtTeDhKT1FJR1Q0T3MxaHYzWGtqTkt1c1AzVDB6cWxYNGdwZV9uVzV6ZF9qTDFScWpNMHBDNHktMTllTEFOVmx0MTNielZMZENyWUU0d0ZpekxIal9lRFZ6Nm1Cd2U?oc=5","date":"2025-05-22","type":"pipeline","source":"European Medical Journal","summary":"New Kids on the Block: Peroxisome Proliferator-Activated Receptor Agonists in Primary Biliary Cholangitis - European Medical Journal","headline":"New Kids on the Block: Peroxisome Proliferator-Activated Receptor Agonists in Primary Biliary Cholangitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxNZVhIbXhlUUlKTkd1ODVhVjNVQmJGcWVsX3pOYzN0OUNLb1VDZjZtLXFSRzZXZkEyLVd5VEZtdDVYeV93Mm9TYlFvSTdqc05ScnFidUNlbEhHaUVjNkRwblpwZUhDM3RPRm1ETk5DZmg2RkxmUktwSTlZWllpTEFRVFpiamJ3Z0Njbi0wVHRYZThNZmd1VDUyUU9zb3pGcW1RSm9aemwtSmNNcGEtc0JGeEdUdk1aUHBLYXlvd0tsV2RQT3lBWHhyOV9fODNhR2V6Z21DY2wyZVpLVTZnSzNzRURYTXdsUV9RUTExMVI2Mnh6cFdaamc?oc=5","date":"2024-09-24","type":"pipeline","source":"European Medical Journal","summary":"Progressive Familial Intrahepatic Cholestasis in Adulthood: Genetics, Diagnosis, Treatment, and Further Research - European Medical Journal","headline":"Progressive Familial Intrahepatic Cholestasis in Adulthood: Genetics, Diagnosis, Treatment, and Further Research","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}